StockNews.com initiated coverage on shares of Cancer Genetics (NASDAQ:CGIX – Free Report) in a report issued on Friday. The firm issued a sell rating on the stock. Cancer Genetics Trading Down 2.3 % Cancer Genetics stock opened at $4.61 on Friday. Cancer Genetics has a twelve month low of $2.11 and a twelve month high […]
Vyant Bio, Inc. (OTCMKTS:VYNT – Get Free Report) shares traded down 13.7% during mid-day trading on Wednesday . The company traded as low as $0.15 and last traded at $0.15. 9,504 shares were traded during trading, a decline of 95% from the average session volume of 195,806 shares. The stock had previously closed at $0.17. […]
Vyant Bio Announces 77,522 Votes Needed to Approve Sale of Assets 175,721 Votes Needed to Approve Winddown of Business Adjournment of Special Meeting of Stockholders streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Cancer Genetics (CGIX) & Its Rivals Critical Contrast themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.